Global InformationSimcere Pharmaceutical information
 | This article needs additional citations for verification. (April 2019) |
| Company type | Listed, SEHK: 2096 |
|---|---|
| Industry | Pharmaceuticals |
| Headquarters | Nanjing, Jiangsu , China |
| Website | www |
Simcere Pharmaceutical Group or Simcere Pharmaceutical (Chinese: 先声药业, SEHK: 2096) is a manufacturer and supplier of branded generic pharmaceuticals in the Chinese market. Its focus is to introduce generic and pharmaceutical products for the treatment of diseases with high incidence and/or mortality rate. The Company has introduced a generic anti-stroke medication under the brand name, Bicun, and an anti-cancer medication under the brand name, Endu. Its products include antibiotics, anti-stroke medications, anti-inflammatory drugs, anti-cancer medications and other medicines. In addition, it has obtained approvals from the China State Food and Drug Administration (SFDA) to manufacture and sell over 210 other products.